Recruitment of Reverse Transcriptase-Cas1 Fusion Proteins by Type VI-A CRISPR-Cas Systems.

Front Microbiol

Structure, Dynamics and Function of Rhizobacterial Genomes, Department of Soil Microbiology and Symbiotic Systems, Estación Experimental del Zaidín, Consejo Superior de Investigaciones Científicas, Granada, Spain.

Published: September 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Type VI CRISPR-Cas systems contain a single effector nuclease (Cas13) that exclusively targets single-stranded RNA. It remains unknown how these systems acquire spacers. It has been suggested that type VI systems with adaptation modules can acquire spacers from RNA bacteriophages, but sequence similarities suggest that spacers may provide immunity to DNA phages. We searched databases for Cas13 proteins with linked RTs. We identified two different type VI-A systems with adaptation modules including an RT-Cas1 fusion and Cas2 proteins. Phylogenetic reconstruction analyses revealed that these adaptation modules were recruited by different effector Cas13a proteins, possibly from RT-associated type III-D systems within the bacterial classes Alphaproteobacteria and Clostridia. These type VI-A systems are predicted to acquire spacers from RNA molecules, paving the way for future studies investigating their role in bacterial adaptive immunity and biotechnological applications.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753606PMC
http://dx.doi.org/10.3389/fmicb.2019.02160DOI Listing

Publication Analysis

Top Keywords

type vi-a
12
acquire spacers
12
adaptation modules
12
crispr-cas systems
8
systems adaptation
8
spacers rna
8
vi-a systems
8
systems
7
type
6
recruitment reverse
4

Similar Publications

CRISPR-Cas systems confer adaptive immunity to their prokaryotic hosts through the process of adaptation, where sequences are captured from foreign nucleic acids and integrated as spacers in the CRISPR array, thereby enabling crRNA-guided interference against new threats. While the Cas1-2 integrase is critical for adaptation, it is absent from many CRISPR-Cas loci, rendering the mechanism of spacer acquisition unclear for these systems. In this study, we show that the RNA-targeting type VI-A CRISPR system of Listeria seeligeri acquires spacers from DNA substrates through the action of a promiscuous Cas1-2 integrase encoded by a co-occurring type II-C system, in a transcription-independent manner.

View Article and Find Full Text PDF

Osteogenesis imperfecta type VI is a rare autosomal recessive disorder characterized by bone fragility and defective mineralization, caused by pathogenic variants in the gene. This study aimed to expand the understanding of OI type VI by analyzing clinical, radiological, and molecular findings in four patients from three unrelated families. Genotyping revealed two novel variants, c.

View Article and Find Full Text PDF

Background: Melasma is a common chronic form of cutaneous hyperpigmentation, particularly prevalent in individuals with Fitzpatrick skin phototypes IV-VI, and it predominantly affects the facial areas of women. The patients with melasma often experience a significant reduction in quality of life. Treating melasma is challenging, as no single gold-standard therapy exists, and higher concentrations (>30%) of trichloroacetic acid peels have been inadequately studied in darker skin phototypes due to the potential complications.

View Article and Find Full Text PDF

The CRISPR-Cas system is a crucial adaptive immune mechanism in prokaryotes, providing defense against invading genetic elements. Among various CRISPR-Cas systems, the type VI-A system, employing RNA-guided RNase Cas13a, has been extensively studied for its ability to target and degrade single-stranded RNA. Anti-CRISPR (Acr) proteins have evolved as natural inhibitors of these systems, with AcrVIA proteins specifically targeting the Cas13a enzyme.

View Article and Find Full Text PDF

Choledochal cyst(CDC) originating from the cystic duct (Type VI A) is uncommon. Dilatation of both the common bile duct (CBD) and cystic duct (Type VI B) is exceptionally rare in children, with only a handful of adult cases documented in medical literature to date. We report a case of a 1-year-old child who was diagnosed with a Type VI B CDC involving dilation of both the cystic and CBDs, confirmed by imaging and histopathology following cholecystectomy, cyst excision, and hepaticoduodenostomy.

View Article and Find Full Text PDF